A strategic blueprint for strengthening respiratory syncytial virus prevention among under-five children in low- and middle-income countries: Bangladesh as a model for new immunisation approaches
Journal of Global Health · 2026
DOI: 10.7189/jogh.16.03013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Global Health, 2026. Verfasst von Saju Bhuiya und 12 weiteren Autor:innen. Beteiligte Einrichtung: International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Developing Countries, Respiratory Syncytial Virus Vaccines, Immunization Programs. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Respiratory syncytial virus (RSV) is the leading cause of respiratory morbidity and mortality in children under five years of age, especially in low- and middle-income countries (LMICs). In 2023, two RSV immunisation options, including a maternal RSV vaccine and a monoclonal antibody (mAb), became approved in several high-income countries. The World Health Organization has recently prequalified the maternal vaccine and the Gavi has committed funding for its introduction, raising the prospect of RSV vaccine availability in LMICs in the near future. This analysis thus underscores the need for country-specific data on the burden of disease and seasonality, as well as the acceptability of new immunisation options and evaluations of their cost-effectiveness. Achieving successful implementation will require health system strengthening, targeted strategies to address unwillingness to vaccinate, securing sustainable financing for immunisation, and ensuring sustained policy commitment. As in many other LMICs, the RSV infection continues to pose a substantial public health concern in Bangladesh. However, evidence gaps persist regarding RSV epidemiology, healthcare system readiness, and public perceptions and willingness regarding new immunisation options. We use Bangladesh as a model to identify gaps, review available evidence, and outline strategies for integrating maternal vaccine and infant mAb into the country's maternal and child health programmes. Lessons drawn from this case study may be directly applicable to other LMICs, offering a pathway to equitable adoption of these life-saving interventions and reducing the substantial global burden of RSV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.
- School of Population Health, University of New South Wales, Sydney, New South Wales, Australia.
- Institute of Health Policy, Management and Evaluation, University of Toronto, Ontario, Canada.
- Institute of Epidemiology, Disease Control and Research, Dhaka, Bangladesh.
- The Eastern Mediterranean Public Health Network, Dhaka, Bangladesh.
- Discipline of Paediatrics and Child Health, School of Clinical Medicine, University of New South Wales Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia.
Zitieren
APA
Bhuiya, S., Chowdhury, F., Islam, M. A., Shuvo, T. A., Aleem, M. A., Basher, A. K., Shoshi, H. R., Pyash, A. S., Hussain, M., Shirin, T., Rahman, M., Homaira, N., & Hassan, M. Z. (2026). A strategic blueprint for strengthening respiratory syncytial virus prevention among under-five children in low- and middle-income countries: Bangladesh as a model for new immunisation approaches. Journal of Global Health. https://doi.org/10.7189/jogh.16.03013
Vancouver
Bhuiya S, Chowdhury F, Islam MA, Shuvo TA, Aleem MA, Basher AK, et al. A strategic blueprint for strengthening respiratory syncytial virus prevention among under-five children in low- and middle-income countries: Bangladesh as a model for new immunisation approaches. Journal of Global Health. 2026. doi:10.7189/jogh.16.03013
BibTeX
@article{Bhuiya2026,
author = {Bhuiya, Saju and Chowdhury, Fahmida and Islam, Md Ariful and Shuvo, Tanzir Ahmed and Aleem, Mohammad Abdul and Basher, Ahamed Khairul and Shoshi, Homayra Rahman and Pyash, Ashrak Shad and Hussain, Mofakhar and Shirin, Tahmina and Rahman, Mahmudur and Homaira, Nusrat and Hassan, Md Zakiul},
title = {A strategic blueprint for strengthening respiratory syncytial virus prevention among under-five children in low- and middle-income countries: Bangladesh as a model for new immunisation approaches},
journal = {Journal of Global Health},
year = {2026},
doi = {10.7189/jogh.16.03013}
}
EUVIMED